＊ When you want to use some Disease-specific iPS cells, please e-mail to the following address.
＊ In relation to the information that are not described below, please e-mail to the following address.
Contact us : cellips.brc
riken.jp
Blue letter cells are available. You obtain the information by clicking the blue letter.
*iPS cells created using the Sendai virus vector are now available
*Terms:
In relation to all iPS cell lines, approval of institutional review board and/or institutional ethical committee regarding the research using iPS cells is necessary.
In relation to all iPS cell lines, commercial use is prohibited.
In relation to the cell lines marked with ◎, (1) the recipient does not need to obtain an approval from the depositor, (2) there is no need of collaboration with the depositor, and (3) for-profit entities can also utilize.
Update : 2020.11.27
| Name of diseases | Patient No. | *Terms | Approval Form | HPS | Reference | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Metabolic diseases | ||||||||||||||
| 1. lysosomal storage disease | ||||||||||||||
| Metachromatic leukodystrophy (MLD) | 1 | HPS0240* | ||||||||||||
| Tay-Sachs’ disease(RCB0697 GM2-1TKB) | 1 | HPS0149* | HPS0150* | |||||||||||
| Niemann-Pick disease, Type C variant biochemical phenotype | 1 | ◎ | Unnecessary | HPS0488 | HPS0489 | HPS0490 | PMID: 23193063 24399248 |
|||||||
| Mucopolysaccharidosis (MPS) | 1 | ◎ | Unnecessary | HPS0660 | HPS0661 | HPS0662 | HPS0663 | HPS0664 | HPS0665 | |||||
| Mucopolysaccharidosis (MPS)VI | 1 | ◎ | Unnecessary | HPS0546 | HPS0547 | HPS0548 | ||||||||
| 2 | ◎ | Unnecessary | HPS0549 | HPS0550 | HPS0551 | |||||||||
| Sanfilippo syndrome, MPS IIIC (acetyl-CoA:heparan-α-Ｄ-glucosaminide N-acetyltransferase deficiency) | 1 | ◎ | Unnecessary | HPS2870 | HPS2871 | HPS2872 | HPS2873 | HPS2874 | HPS2875 | |||||
| Fabry disease | 1 | ◎ | Unnecessary | HPS3284 | HPS3285 | HPS3286 | HPS3287 | HPS3288 | HPS3289 | |||||
| Fabry disease, symptomatic heterozygate / unknown genetic etiology | 1 | ◎ | Unnecessary | HPS2108 | HPS2109 | HPS2110 | HPS2111 | HPS2112 | HPS2113 | |||||
| Fabry disease, mutation of pseudogene | 1 | ◎ | Unnecessary | HPS1632 | HPS1633 | HPS1634 | HPS1635 | HPS1636 | HPS1637 | |||||
| GM1-gangliosidosis | 1 | ◎ | Unnecessary | HPS1532 | HPS1533 | HPS1534 | HPS1535 | HPS1536 | HPS1537 | |||||
| 2 | ◎ | Unnecessary | HPS2337 | HPS2338 | HPS2339 | HPS2340 | ||||||||
| Hunter syndrome, unknown genetic etiology | 1 | ◎ | Unnecessary | HPS2359 | HPS2360 | HPS2361 | HPS2362 | HPS2363 | HPS2364 | |||||
| Hunter syndrome, recombination of IDS preudogene | 1 | ◎ | Unnecessary | HPS1478 | HPS1479 | HPS1480 | HPS1481 | HPS1482 | HPS1483 | |||||
| Cystinosis | 1 | ◎ | Unnecessary | HPS1427 | HPS1428 | HPS1429 | ||||||||
| Galactosialidosis, adult type | 1 | ◎ | Unnecessary | HPS1936 | HPS1937 | HPS1938 | HPS1939 | HPS1940 | HPS1941 | |||||
| Gaucher’s disease, type 1.1 / mutation in glucocerebrosidase | 1 | ◎ | Unnecessary | HPS2383 | HPS2384 | HPS2385 | HPS2386 | HPS2387 | HPS2388 | |||||
| 2. Adrenoleukodystrophy (ALD) | ||||||||||||||
| Adrenoleukodystrophy (ALD) | 1 | ◎ | Unnecessary | HPS1090 | HPS1091 | HPS1092 | HPS1093 | HPS1094 | HPS1095 | |||||
| 2 | ◎ | Unnecessary | HPS1096 | HPS1097 | HPS1098 | HPS1099 | HPS1100 | HPS1101 | ||||||
| 3. Mitochondrial diseases | ||||||||||||||
| Mitochondrial diseases | 1 | HPS0070* | HPS0071* | |||||||||||
| 2 | ◎ | Unnecessary | HPS0458 | HPS0459 | HPS0460 | PMID: 23193063 24399248 |
||||||||
| 3 | ◎ | Unnecessary | HPS0461 | HPS0462 | HPS0463 | PMID: 23193063 24399248 |
||||||||
| 4 | ◎ | Unnecessary | HPS1853 | |||||||||||
| 5 | ◎ | Unnecessary | HPS1854 | |||||||||||
| Mitochondrial diseases, MELAS | 1 | ◎ | Unnecessary | HPS2864 | HPS2865 | HPS2866 | HPS2867 | HPS2868 | HPS2869 | |||||
| 4.Amyloid neuropathy | ||||||||||||||
| Amyloid neuropathy, Familial type | 1 | HPS0224* | HPS0225* | HPS0226* | ||||||||||
| 2 | HPS0227* | HPS0228* | ||||||||||||
| Systemic amyloidosis, hereditary amyloidosis | 1 | ◎ | Unnecessary | HPS2018 | HPS2019 | HPS2020 | HPS2021 | HPS2022 | HPS2023 | |||||
| Systemic amyloidosis, AL amyloidosis | 1 | ◎ | Unnecessary | HPS2024 | HPS2025 | HPS2026 | HPS2027 | HPS2028 | HPS2029 | |||||
| 5.Wilson’s disease | ||||||||||||||
| Wilson’s disease（RCB0390 NCU-F3） | 1 | ◎ | Unnecessary | HPS0049 | HPS0050 | HPS0051 | HPS0052 | |||||||
| Wilson’s disease（RCB0391 NCU-F4） | 2 | ◎ | Unnecessary | HPS0053 | HPS0054 | HPS0055 | HPS0056 | |||||||
| Wilson’s disease（RCB0395 NCU-F8） | 3 | ◎ | Unnecessary | HPS0045 | HPS0046 | HPS0047 | HPS0048 | |||||||
| Wilson’s disease, unknown genetic etiology | 1 | ◎ | Unnecessary | HPS2804 | HPS2805 | HPS2806 | HPS2807 | HPS2808 | HPS2809 | |||||
| 6.Phenylketonuria | ||||||||||||||
| Phenylketonuria, Phenylalanine hydroxylase deficiency | 1 | ◎ | Unnecessary | HPS2858 | HPS2859 | HPS2860 | HPS2861 | HPS2862 | HPS2863 | |||||
| 7. Ornithine transcarbamylase deficiency (OTCD) | ||||||||||||||
| Ornithine transcarbamylase deficiency (OTCD) (RCB0492 OTCD1TKB) | 1 | Unnecessary | HPS0087* | |||||||||||
| 8. Glycogen storage disease | ||||||||||||||
| Glycogen storage disease, GSD type V (muscle glycogen phosphorylase deficiency) | 1 | ◎ | Unnecessary | HPS3254 | HPS3255 | HPS3256 | HPS3257 | HPS3258 | HPS3259 | |||||
| Pompe’s disease | 1 | HPS0175* | HPS0176* | HPS0177* | ||||||||||
| Pompe’s disease, adult type / unknown genetic etiology | 1 | ◎ | Unnecessary | HPS2389 | HPS2390 | HPS2391 | HPS2392 | HPS2393 | HPS2394 | |||||
| 9. Glycogen storage disease | ||||||||||||||
| Glycogen storage disease, Type 1a | 1 | HPS3924* | HPS3925* | HPS3926* | ||||||||||
| Glycogen storage disease, Type 1b | 1 | HPS0064* |
